<DOC>
	<DOC>NCT01186926</DOC>
	<brief_summary>The overall goal of the study is to evaluate the safety, efficacy and therapy settings of the HGNS System for stimulating the hypoglossal nerve to help maintain an open airway in subjects with obstructive sleep apnea (OSA).</brief_summary>
	<brief_title>Australian Clinical Study of the Apnex Medical HGNS System to Treat Obstructive Sleep Apnea</brief_title>
	<detailed_description />
	<mesh_term>Apnea</mesh_term>
	<mesh_term>Sleep Apnea Syndromes</mesh_term>
	<mesh_term>Sleep Apnea, Obstructive</mesh_term>
	<criteria>Eligibility Criteria 1. Previously diagnosed with moderate to severe obstructive sleep apnea. 2. Subject has failed or does not tolerate CPAP treatment. 3. Age between 21 and 70 years. 4. Body mass index (BMI) less than or equal to 40</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>December 2011</verification_date>
	<keyword>Obstructive sleep apnea</keyword>
	<keyword>OSA</keyword>
	<keyword>hypoglossal nerve stimulation</keyword>
	<keyword>sleep apnea</keyword>
</DOC>